• Thurs news: AbbVie Parkinson’s drug. Arch raises $3B biotech fund. Biogen dropping failed Sage tremor drug. AZ gets sought-after Tagrisso OK. Pfizer withdrawing sickle cell med. See more on our front page

Welcome to Sonic US









So how did those changes work out for you? much more efficient now or are you now seeing the real problem.
good luck - the industry is extremely challenging with all the work force issues.
 




the place continues to lose accounts and corporate has zero message for we the people of the lab. looks like consolidations are in the mix but you would never know because they are too smart and we are too stupid. not nice people here.
 








The ivory tower lives on. no clue!! and yet they feel the brains in the ivory tower are the only brains available on planet earth. consolidations with regional tc facilities on the way:) as shortages and intelligence will be lacking